Pfizer, BioNTech Start Approval Process For Covid-19 Vaccine Candidate In EuropeInvestors Business Daily • 10/06/20
Pfizer and BioNTech says European Medicines Agency to review data from COVID-19 vaccine trial on rolling basisMarket Watch • 10/06/20
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2GlobeNewsWire • 10/06/20
Pfizer, BioNTech, and Regeneron Hit With Patent Lawsuits Over COVID-19 Drugs and VaccinesThe Motley Fool • 10/05/20
Pfizer and BioNTech Have Enrolled 83% of Their Up-Sized Coronavirus Vaccine TrialThe Motley Fool • 10/05/20
3 Reasons Why You Probably Won't Receive a Coronavirus Vaccine Shot by the End of 2020The Motley Fool • 09/17/20
Here's the Company That Bill Gates Thinks Is the Clear Coronavirus Vaccine LeaderThe Motley Fool • 09/17/20
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021GlobeNewsWire • 09/17/20
Germany Awards $743 Million to BioNTech and CureVac for Coronavirus Vaccine DevelopmentThe Motley Fool • 09/15/20
Covid Roundup: BioNTech Boosts Funding; Novavax Boosts ManufacturingInvestors Business Daily • 09/15/20
BioNTech shares jump premarket on news of 375 million euros in German funding for COVID-19 vaccineMarket Watch • 09/15/20
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162GlobeNewsWire • 09/15/20
Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical TrialThe Motley Fool • 09/13/20